Strength of the biomedical technology cluster
In response to the global medical needs for ageing population, the STSP has been actively developing the smart biomedical technologies for years, in addition to the existing manufacture of vaccines, pharmaceuticals and clinical diagnostics within the cluster, which has proudly become the largest in the southern Taiwan.
Taking advantages of the advanced ICT and BIO industries, STSP launches various programs, such as investment attraction, start-ups acceleration, grants on R&D, industry-academia cooperation, clinical trials, training courses, acquisition of medical certificate, international marketing, etc., with the aim of strengthening the cluster’s ecosystem and sustainable development, and constructing the competitive high-quality precision health industry. The results of these efforts are reflected in the steadily growing revenues of tenant companies in both domestic and international markets.